rvallee
Senior Member (Voting Rights)
Prioritization of potential causative genes for schizophrenia in placenta
https://www.nature.com/articles/s41467-023-38140-1
Abstract
Our earlier work has shown that genomic risk for schizophrenia converges with early life complications in affecting risk for the disorder and sex-biased neurodevelopmental trajectories. Here, we identify specific genes and potential mechanisms that, in placenta, may mediate such outcomes. We performed TWAS in healthy term placentae (N = 147) to derive candidate placental causal genes that we confirmed with SMR; to search for placenta and schizophrenia-specific associations, we performed an analogous analysis in fetal brain (N = 166) and additional placenta TWAS for other disorders/traits. The analyses in the whole sample and stratifying by sex ultimately highlight 139 placenta and schizophrenia-specific risk genes, many being sex-biased; the candidate molecular mechanisms converge on the nutrient-sensing capabilities of placenta and trophoblast invasiveness. These genes also implicate the Coronavirus-pathogenesis pathway and showed increased expression in placentae from a small sample of SARS-CoV-2-positive pregnancies. Investigating placental risk genes for schizophrenia and candidate mechanisms may lead to opportunities for prevention that would not be suggested by study of the brain alone.
Conclusion
In conclusion, our findings, while not detracting from the importance of gene expression in brain for schizophrenia risk, reveal a larger picture that includes placenta: both placenta and brain might contribute to early and reversible trajectories of risk for the disorder, but most research on brain development has been exclusively focused on the brain. Neglecting the investigation of placental mechanisms of risk may miss relevant opportunities for prevention.
https://www.nature.com/articles/s41467-023-38140-1
Abstract
Our earlier work has shown that genomic risk for schizophrenia converges with early life complications in affecting risk for the disorder and sex-biased neurodevelopmental trajectories. Here, we identify specific genes and potential mechanisms that, in placenta, may mediate such outcomes. We performed TWAS in healthy term placentae (N = 147) to derive candidate placental causal genes that we confirmed with SMR; to search for placenta and schizophrenia-specific associations, we performed an analogous analysis in fetal brain (N = 166) and additional placenta TWAS for other disorders/traits. The analyses in the whole sample and stratifying by sex ultimately highlight 139 placenta and schizophrenia-specific risk genes, many being sex-biased; the candidate molecular mechanisms converge on the nutrient-sensing capabilities of placenta and trophoblast invasiveness. These genes also implicate the Coronavirus-pathogenesis pathway and showed increased expression in placentae from a small sample of SARS-CoV-2-positive pregnancies. Investigating placental risk genes for schizophrenia and candidate mechanisms may lead to opportunities for prevention that would not be suggested by study of the brain alone.
Conclusion
In conclusion, our findings, while not detracting from the importance of gene expression in brain for schizophrenia risk, reveal a larger picture that includes placenta: both placenta and brain might contribute to early and reversible trajectories of risk for the disorder, but most research on brain development has been exclusively focused on the brain. Neglecting the investigation of placental mechanisms of risk may miss relevant opportunities for prevention.
Last edited: